Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

SKYEPHARMA PLC (SKP)

12
Delayed Quote. Delayed London Stock Exchange - 05/22 11:35:18 am
291 GBp   -2.02%
05/13 BARCLAYS : supports Skyepharma with a GBP25 million credit facility ..
05/13 SKYEPHARMA : confident of outlook
05/12 SKYEPHARMA : Confident In 2015 Outlook As Momentum Continues
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
290(c) 288(c) 296(c) 297(c) 291(c) Last
90 394 90 027 541 730 118 106 33 183 Volume
0.00% -0.69% +2.78% +0.34% -2.02% Change
More quotes
Financials ( GBP)
Sales 2015 93,4 M
EBIT 2015 23,8 M
Net income 2015 8 151 M
Finance 2015 22,5 M
Yield 2015 -
Sales 2016 99,9 M
EBIT 2016 24,6 M
Net income 2016 9 424 M
Finance 2016 35,4 M
Yield 2016 -
PER 2015 16,72
PER 2016 15,00
EV / Sales 2015 3,02x
EV / Sales 2016 2,70x
Capitalization 305 M
More Financials
Company
SkyePharma Plc is a UK based pharmaceutical company.It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products.The company approves products in the areas of oral, inhalation and topical delivery.SkyePharma was founded by... 
Sector
Pharmaceuticals
Calendar
08/20Earnings Release
More about the company
Surperformance© ratings of SkyePharma PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on SKYEPHARMA PLC
05/13 BARCLAYS : supports Skyepharma with a GBP25 million credit facility to support o..
05/13 SKYEPHARMA : confident of outlook
05/12 SKYEPHARMA : Confident In 2015 Outlook As Momentum Continues
03/25 SKYEPHARMA : mixed results
03/24 SKYEPHARMA : Confident In Prospects Despite Wider Loss In 2014
02/13 SKYEPHARMA : To Repay Remainder Of CRC Finance Facility Early
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
More news
Sector news : Pharmaceuticals - NEC
07:39a GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart SKYEPHARMA PLC
Duration : Period :
SkyePharma PLC Technical Analysis Chart | SKP | GB00B3BFNB64 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions